MEDEOR, Truffle Capital's new BioMedTech Fund, qualified by institutional investors through the Tibi committee
The management company has just unveiled its new Fund called Truffle MEDEOR
Truffle Capital marks its ambition while wishing to respect its DNA. The management company founded by Philippe Pouletty and Bernard-Louis Roques in 2001, and directed by Patrick Kron, has just lifted the veil on its new fund, named Truffle MEDEOR. "This vehicle could total between 600 and 800 million euros, if successfully raised. It would then be the largest European Fund in the field of MedTech", Philippe Pouletty then underlined.
Also to be discovered
Philippe Pouletty and Hartmut J. Ehrlich - ABIVAX - Covid-19 Quarantine
WCBS NewsRadio 880: CEO RADIO
Investors Search for Promising Covid Cures
The race to develop vaccines and treatments to build immunity to the novel coronavirus ...